{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T19:55:02Z","timestamp":1789934102116,"version":"4.0.1"},"reference-count":106,"publisher":"JLE","issue":"1","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N\u00e9phrologie &amp; Th\u00e9rapeutique"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.nephro.2009.02.006","type":"journal-article","created":{"date-parts":[[2009,4,3]],"date-time":"2009-04-03T09:15:55Z","timestamp":1238750155000},"page":"58-74","source":"Crossref","is-referenced-by-count":22,"title":["Toxicit\u00e9 r\u00e9nale des m\u00e9dicaments"],"prefix":"10.1684","volume":"6","author":[{"given":"Svetlana","family":"Karie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Launay-Vacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert","family":"Deray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Isnard-Bagnis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"18929","reference":[{"key":"10.1016\/j.nephro.2009.02.006_bib1","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1053\/ajkd.2002.32766","article-title":"Hospital-acquired renal insufficiency","volume":"39","author":"Nash","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2009.02.006_bib2","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.294.7.813","article-title":"Beginning and ending supportive therapy for the kidney (BEST Kidney) investigators. Acute renal failure in critically ill patients: a multinational, multicenter study","volume":"294","author":"Uchino","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.nephro.2009.02.006_bib3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/978-1-4684-8240-9_16","article-title":"Drug-associated acute renal failure. A prospective collaborative study of 81 biopsied patients","volume":"212","author":"Kleinknecht","year":"1987","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.nephro.2009.02.006_bib4","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1093\/ndt\/gfl399","article-title":"Use of renal risk drugs in hospitalized patients with impaired renal function \u2013 an underestimated problem?","volume":"21","author":"Blix","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2009.02.006_bib5","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1001\/jama.1996.03530430033035","article-title":"The effect of acute renal failure on mortality. A cohort analysis","volume":"275","author":"Levy","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.nephro.2009.02.006_bib6","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/01.ccx.0000247445.71381.72","article-title":"The long-term outcome after acute renal failure","volume":"12","author":"Bagshaw","year":"2006","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.nephro.2009.02.006_bib7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3810\/pgm.1996.12.128","article-title":"Drug-induced nephrotoxicity: the crucial role of risk factors","volume":"100","author":"Thatte","year":"1996","journal-title":"Postgrad Med"},{"key":"10.1016\/j.nephro.2009.02.006_bib8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/ndt\/gfg464","article-title":"The changing profile of acute tubulointerstitial nephritis","volume":"19","author":"Baker","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2009.02.006_bib9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1136\/bmj.320.7227.93","article-title":"Drug points: Acute renal failure induced by topical ketoprofen","volume":"320","author":"Krummel","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.nephro.2009.02.006_bib10","first-page":"1092","article-title":"The percutaneous absorption of diclofenac","volume":"36","author":"Riess","year":"1986","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.nephro.2009.02.006_bib11","first-page":"559","article-title":"Percutaneous ibuprofen therapy with Trauma-Dolgit gel: bioequivalence studies","volume":"15","author":"Berner","year":"1989","journal-title":"Drugs Exp Clin Res"},{"key":"10.1016\/j.nephro.2009.02.006_bib12","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0755-4982(04)98637-X","article-title":"Effets r\u00e9naux et cardiovasculaires des anti-inflammatoires non st\u00e9ro\u00efdiens et des coxibs","volume":"33","author":"Deray","year":"2004","journal-title":"Presse Med"},{"key":"10.1016\/j.nephro.2009.02.006_bib13","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0009-9236(99)70056-1","article-title":"Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects","volume":"66","author":"Rossat","year":"1999","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.nephro.2009.02.006_bib14","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1345\/aph.1A395","article-title":"Aminoglycoside-associated nephrotoxicity in the elderly","volume":"37","author":"Baciewicz","year":"2003","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.nephro.2009.02.006_bib15","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000067797","article-title":"Aminoglycoside-induced reversible tubular dysfunction","volume":"67","author":"Alexandridis","year":"2003","journal-title":"Pharmacology"},{"key":"10.1016\/j.nephro.2009.02.006_bib16","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/bmj.312.7027.338","article-title":"Single or multiple daily doses of aminoglycosides: a meta-analysis","volume":"312","author":"Barza","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.nephro.2009.02.006_bib17","first-page":"CD002009","article-title":"Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis","author":"Smyth","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nephro.2009.02.006_bib18","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1053\/ajkd.2002.35675","article-title":"Acute renal failure due to rifampicin: a study of 25 patients","volume":"40","author":"Muthukumar","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2009.02.006_bib19","doi-asserted-by":"crossref","first-page":"284","DOI":"10.5414\/CNP65284","article-title":"Crescentic glomerulonephritis associated with rifampicin in a patient co-infected with tuberculosis and human immunodeficiency virus","volume":"65","author":"Wen","year":"2006","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.nephro.2009.02.006_bib20","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1159\/000013389","article-title":"Isoniazid-induced crescentic glomerulonephritis in a child with a positive tuberculin skin test","volume":"18","author":"Brik","year":"1998","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.nephro.2009.02.006_bib21","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1159\/000189178","article-title":"Acute interstitial nephritis due to cefotaxime","volume":"73","author":"al Shohaib","year":"1996","journal-title":"Nephron"},{"key":"10.1016\/j.nephro.2009.02.006_bib22","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1081\/JDI-100100869","article-title":"Cephotaxime-associated allergic interstitial nephritis and MPO-ANCA positive vasculitis","volume":"22","author":"Feriozzi","year":"2000","journal-title":"Ren Fail"},{"key":"10.1016\/j.nephro.2009.02.006_bib23","doi-asserted-by":"crossref","unstructured":"Kapur G, Valentini RP, Mattoo TK, Warrier I, Imam AA. Ceftriaxone induced hemolysis complicated by acute renal failure. Pediatr Blood Cancer 2008;50:139\u201342.","DOI":"10.1002\/pbc.20839"},{"key":"10.1016\/j.nephro.2009.02.006_bib24","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1469-0691.1999.tb00441.x","article-title":"An adult case of fatal hemolysis induced by ceftriaxone","volume":"5","author":"Punar","year":"1999","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.nephro.2009.02.006_bib25","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1007\/s001340000598","article-title":"Ceftriaxone-induced immune haemolysis: two case reports and a concise review of the literature","volume":"26","author":"Seltsam","year":"2000","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.nephro.2009.02.006_bib26","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1136\/adc.2003.044156","article-title":"Nephrolithiasis associated with ceftriaxone therapy: a prospective study in 51 children","volume":"89","author":"Avci","year":"2004","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.nephro.2009.02.006_bib27","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/jac\/20.5.697","article-title":"Teicoplanin: renal tolerance and pharmacokinetics in rats","volume":"20","author":"Marre","year":"1987","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.nephro.2009.02.006_bib28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/1120009X.2000.11782314","article-title":"Comparative safety of teicoplanin and vancomycin","volume":"12","author":"Wood","year":"2000","journal-title":"J Chemother"},{"key":"10.1016\/j.nephro.2009.02.006_bib29","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2165\/00003088-200443060-00004","article-title":"Teicoplanin in patients with acute leukaemia and febrile neutropenia: a special population benefiting from higher dosages","volume":"43","author":"Pea","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.nephro.2009.02.006_bib30","doi-asserted-by":"crossref","first-page":"e185","DOI":"10.1016\/j.jinf.2005.01.004","article-title":"Teicoplanin-induced vasculitis with cutaneous and renal involvement","volume":"51","author":"Logan","year":"2005","journal-title":"J Infect"},{"key":"10.1016\/j.nephro.2009.02.006_bib31","doi-asserted-by":"crossref","first-page":"155","DOI":"10.5414\/CNP64155","article-title":"Vancomycin-induced hypersensitivity reaction with acute renal failure: resolution following cyclosporine treatment","volume":"64","author":"Zuliani","year":"2005","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.nephro.2009.02.006_bib32","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/jac\/25.4.679","article-title":"Nephrotoxicity of vancomycin, alone and with an aminoglycoside","volume":"25","author":"Rybak","year":"1990","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.nephro.2009.02.006_bib33","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/jac\/32.2.325","article-title":"Nephrotoxicity of vancomycin and aminoglycoside therapy separately and in combination","volume":"32","author":"Goetz","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.nephro.2009.02.006_bib34","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1002\/(SICI)1097-0142(19981215)83:12<2597::AID-CNCR27>3.0.CO;2-L","article-title":"Mississippi mud in the 1990s. Risks and outcomes of vancomycin-associated toxicity in general oncology practice","volume":"83","author":"Elting","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.nephro.2009.02.006_bib35","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/01.inf.0000141753.41486.ff","article-title":"Recurrent acute interstitial nephritis induced by azithromycin","volume":"23","author":"Soni","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.nephro.2009.02.006_bib36","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000187967","article-title":"Acute interstitial nephritis with septicemia and erythromycin","volume":"67","author":"van der Sande","year":"1994","journal-title":"Nephron"},{"key":"10.1016\/j.nephro.2009.02.006_bib37","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1177\/106002809202601010","article-title":"Cloxacillin-induced acute tubulo interstitial nephritis","volume":"26","author":"Garcia-Ortiz","year":"1992","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.nephro.2009.02.006_bib38","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1007\/s00134-002-1244-3","article-title":"Piperacillin-induced magnesium and potassium loss in intensive care unit patients","volume":"28","author":"Polderman","year":"2002","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.nephro.2009.02.006_bib39","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1093\/ndt\/gfl554","article-title":"Ciprofloxacin-induced ANCA-negative cutaneous and renal vasculitis\u2014resolution with drug withdrawal","volume":"22","author":"Storsley","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2009.02.006_bib40","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.1053\/ajkd.2003.50064","article-title":"Levofloxacin-induced granulomatous interstitial nephritis","volume":"41","author":"Ramalakshmi","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2009.02.006_bib41","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1345\/aph.1A474","article-title":"Nephrotoxicity and purpura associated with levofloxacin","volume":"36","author":"Famularo","year":"2002","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.nephro.2009.02.006_bib42","first-page":"356","article-title":"Levofloxacin-induced allergic interstitial nephritis","volume":"54","author":"Solomon","year":"2000","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.nephro.2009.02.006_bib43","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.clinthera.2005.08.008","article-title":"Acute interstitial nephritis associated with moxifloxacin use","volume":"27","author":"Argirov","year":"2005","journal-title":"Clin Ther"},{"key":"10.1016\/j.nephro.2009.02.006_bib44","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1592\/phco.23.10.1190.32753","article-title":"Acute tubular necrosis associated with propylene glycol from concomitant administration of intravenous lorazepam and trimethoprim-sulfamethoxazole","volume":"23","author":"Hayman","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.nephro.2009.02.006_bib45","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1345\/aph.1D179","article-title":"Adverse reactions to trimethoprim\/sulfamethoxazole in AIDS","volume":"37","author":"Floris-Moore","year":"2003","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.nephro.2009.02.006_bib46","doi-asserted-by":"crossref","first-page":"105","DOI":"10.7326\/0003-4819-137-2-200207160-00008","article-title":"Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS","volume":"137","author":"Johnson","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.nephro.2009.02.006_bib47","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00431-006-0208-y","article-title":"Hypokaliemic rhabdomyolysis in a child due to amphotericin B therapy","volume":"166","author":"da Silva","year":"2007","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.nephro.2009.02.006_bib48","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1086\/313498","article-title":"Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis","volume":"29","author":"Wingard","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.nephro.2009.02.006_bib49","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00041552-200203000-00005","article-title":"Recent developments in toxic nephropathy","volume":"11","author":"Wali","year":"2002","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.nephro.2009.02.006_bib50","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1053\/j.ajkd.2006.11.033","article-title":"Membranous nephropathy associated with fluconazole treatment","volume":"49","author":"Shin","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2009.02.006_bib51","first-page":"367","article-title":"Cyclodextrin nephrosis in the rat","volume":"83","author":"Frank","year":"1976","journal-title":"Am J Pathol"},{"key":"10.1016\/j.nephro.2009.02.006_bib52","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1365-2133.1996.tb07638.x","article-title":"Renal impairment associated with oral terbinafine","volume":"134","author":"Lee","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.nephro.2009.02.006_bib53","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00062752-200109000-00004","article-title":"Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome","volume":"8","author":"Medina","year":"2001","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.nephro.2009.02.006_bib54","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.7326\/0003-4819-135-12-200112180-00008","article-title":"Quinine-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: frequency, clinical features, and long-term outcomes","volume":"135","author":"Kojouri","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.nephro.2009.02.006_bib55","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1055\/s-2005-925474","article-title":"Drug-induced thrombotic microangiopathy","volume":"31","author":"Zakarija","year":"2005","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.nephro.2009.02.006_bib56","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/infdis\/151.2.362","article-title":"Adverse effects of high-dose intravenous acyclovir in ambulatory patients with acute herpes zoster","volume":"151","author":"Bean","year":"1985","journal-title":"J Infect Dis"},{"key":"10.1016\/j.nephro.2009.02.006_bib57","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1097\/00006454-198611000-00027","article-title":"Acyclovir crystalluria","volume":"5","author":"Potter","year":"1986","journal-title":"Pediatr Infect Dis"},{"key":"10.1016\/j.nephro.2009.02.006_bib58","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1523-1755.2004.00359.x","article-title":"Down-regulation of Na+ transporters and AQP2 is responsible for acyclovir-induced polyuria and hypophosphatemia","volume":"65","author":"Andrade","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2009.02.006_bib59","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/jnnp.61.3.325","article-title":"Central diabetes insipidus: a complication of herpes simplex encephalitis","volume":"61","author":"Canton","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nephro.2009.02.006_bib60","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1124\/mol.56.3.570","article-title":"The antiviral nucleotide analogs cidofovir and adefovir are novel substrates for human and rat renal organic anion transporter 1","volume":"56","author":"Cihlar","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.nephro.2009.02.006_bib61","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0022-3565(24)29264-8","article-title":"Nucleoside phosphonate interactions with multiple organic anion transporters in renal proximal tubule","volume":"299","author":"Miller","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.nephro.2009.02.006_bib62","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1124\/mol.106.028233","article-title":"Functional involvement of multidrug resistance associated protein 4 (MRP4\/ABCC4) in the renal elimination of the anti-viral drugs, adefovir and tenofovir","volume":"71","author":"Imaoka","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.nephro.2009.02.006_bib63","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/ndt\/17.1.148","article-title":"Cidofovir-induced end-stage renal failure","volume":"17","author":"Meier","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2009.02.006_bib64","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/135965350501000110","article-title":"Tubular cell apoptosis and cidofovir-induced acute renal failure","volume":"10","author":"Ortiz","year":"2005","journal-title":"Antivir Ther"},{"key":"10.1016\/j.nephro.2009.02.006_bib65","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/00007890-200202270-00033","article-title":"Topical use of cidofovir induced acute renal failure","volume":"73","author":"Bienvenu","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.nephro.2009.02.006_bib66","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1517\/14740338.5.2.275","article-title":"Antiretroviral therapy and the kidney: balancing benefit and risk in patients with HIV infection","volume":"5","author":"Wyatt","year":"2006","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.nephro.2009.02.006_bib67","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000167987","article-title":"Foscarnet nephrotoxicity: mechanism, incidence and prevention","volume":"9","author":"Deray","year":"1989","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.nephro.2009.02.006_bib68","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1681\/ASN.V83361","article-title":"Nephrotoxicity of acyclovir and ganciclovir in rats: evaluation of glomerular hemodynamics","volume":"8","author":"Dos Santos Mde","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2009.02.006_bib69","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJM199104113241501","article-title":"A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants","volume":"324","author":"Schmidt","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2009.02.006_bib70","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s00134-005-2808-9","article-title":"Acute renal failure and severe neurotoxicity following valacyclovir","volume":"31","author":"Carlon","year":"2005","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.nephro.2009.02.006_bib71","first-page":"S132","article-title":"Valaciclovir-related neuro- and nephro-toxicity in two geriatric patients","volume":"22","author":"Catalano","year":"2005","journal-title":"G Ital Nefrol"},{"key":"10.1016\/j.nephro.2009.02.006_bib72","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005792-199709000-00004","article-title":"Manifestations resembling thrombotic microangiopathy in patients with advanced human immunodeficiency virus (HIV) disease in a cytomegalovirus prophylaxis trial (ACTG 204)","volume":"76","author":"Bell","year":"1997","journal-title":"Medicine"},{"key":"10.1016\/j.nephro.2009.02.006_bib73","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1001\/archinte.160.11.1705","article-title":"Valacyclovir hydrochloride therapy and thrombotic thrombocytopenic purpura in an HIV-infected patient","volume":"160","author":"Rivaud","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.nephro.2009.02.006_bib74","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1081\/NCN-100002341","article-title":"Human renal organic anion transporter 1 (hOAT1) and its role in the nephrotoxicity of antiviral nucleotide analogs","volume":"20","author":"Cihlar","year":"2001","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.nephro.2009.02.006_bib75","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.nephro.2005.06.011","article-title":"Effet de l\u2019inhibition des transporteurs OAT1 et MRP2 sur la clairance de l\u2019ad\u00e9fovir","volume":"1","author":"Servais","year":"2005","journal-title":"Nephrol Ther"},{"key":"10.1016\/j.nephro.2009.02.006_bib76","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1053\/hupa.2001.25586","article-title":"Adefovir nephrotoxicity: possible role of mitochondrial DNA depletion","volume":"32","author":"Tanji","year":"2001","journal-title":"Hum Pathol"},{"key":"10.1016\/j.nephro.2009.02.006_bib77","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa020681","article-title":"Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B","volume":"348","author":"Marcellin","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2009.02.006_bib78","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/ndt\/gfg505","article-title":"The renal tolerance of low-dose adefovir dipivoxil by lamivudine-resistant individuals co-infected with hepatitis B and HIV","volume":"19","author":"Hannon","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2009.02.006_bib79","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1523-1755.2004.00866.x","article-title":"Renal safety of adefovir dipivoxil in patients with chronic hepatitis B: two double-blind, randomized, placebo-controlled studies","volume":"66","author":"Izzedine","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2009.02.006_bib80","first-page":"1441","article-title":"Acute renal failure associated with alpha-interferon therapy for chronic hepatitis B","volume":"10","author":"Miranda-Guardiola","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2009.02.006_bib81","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S0272-6386(96)90389-3","article-title":"Focal segmental glomerulosclerosis with acute renal failure associated with \u03b1-interferon therapy","volume":"28","author":"Coroneos","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2009.02.006_bib82","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1093\/ndt\/13.5.1316","article-title":"Interferon-induced acute renal failure in nephrotic syndrome","volume":"13","author":"Al Harbi","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2009.02.006_bib83","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S0272-6386(99)70140-X","article-title":"Exacerbation of glomerulonephritis in subjects with chronic hepatitis C virus infection after interferon therapy","volume":"33","author":"Ohta","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2009.02.006_bib84","first-page":"465","article-title":"Syndrome n\u00e9phrotique avec insuffisance r\u00e9nale aigu\u00eb par hyalinose segmentaire et focale chez un malade trait\u00e9 par interf\u00e9ron alpha pour une h\u00e9patite chronique virale C","volume":"4","author":"Bella\u00efche","year":"2000","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.nephro.2009.02.006_bib85","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1007\/s005350200141","article-title":"Acute onset of nephrotic syndrome during interferon-alpha retreatment for chronic active hepatitis C","volume":"37","author":"Nishimura","year":"2002","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.nephro.2009.02.006_bib86","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0272-6386(04)00828-5","article-title":"A woman with chronic hepatitis C infection and nephrotic syndrome who developed multiple renal lesions after interferon alfa therapy","volume":"44","author":"Fisher","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2009.02.006_bib87","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1093\/ndt\/gfh336","article-title":"Combination pegylated interferon and ribavirin therapy precipitating acute renal failure and exacerbating IgA nephropathy","volume":"19","author":"Gordon","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2009.02.006_bib88","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S0272-6386(99)70160-5","article-title":"Interferon therapy: a double-edged sword?","volume":"33","author":"Cattran","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2009.02.006_bib89","first-page":"2104","article-title":"Recombinant a-interferon in renal allograft recipients with chronic hepatitis C","volume":"10","author":"\u00d6zg\u00fcr","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2009.02.006_bib90","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1159\/000189444","article-title":"Acute renal failure in kidney transplant patients treated with interferon alpha 2b for chronic hepatitis C","volume":"74","author":"Rostaing","year":"1996","journal-title":"Nephron."},{"key":"10.1016\/j.nephro.2009.02.006_bib91","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00007890-199808270-00010","article-title":"Retrospective study on the impact of hepatitis c virus infection on kidney transplant patients over 20 years","volume":"66","author":"Hanafusa","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.nephro.2009.02.006_bib92","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/S0140-6736(05)62957-1","article-title":"Pancreatorenal syndrome associated with combination antiretroviral therapy in HIV infection","volume":"349","author":"Stricker","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2009.02.006_bib93","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/sj.ki.5001668","article-title":"Therapy with lamivudine and steroids in a patient with acute hepatitis B and rapidly progressive glomerulonephritis","volume":"70","author":"Di Marco","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2009.02.006_bib94","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1111\/j.1523-1755.2005.00591.x","article-title":"Lamivudine in hepatitis B-associated membranous nephropathy","volume":"68","author":"Tang","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2009.02.006_bib95","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1053\/ajkd.2000.19114","article-title":"Acute renal failure in an HIV-positive 50-year-old man","volume":"36","author":"Krishnan","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2009.02.006_bib96","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1097\/01.aids.0000189861.44311.ed","article-title":"Severe rhabdomyolysis during a hypersensitivity reaction to abacavir in a patient treated with ciprofibrate","volume":"19","author":"Fontaine","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.nephro.2009.02.006_bib97","first-page":"296","article-title":"Abacavir-induced reversible Fanconi syndrome with nephrogenic diabetes insipidus in a patient with acquired immunodeficiency syndrome","volume":"52","author":"Ahmad","year":"2006","journal-title":"J Postgrad Med"},{"key":"10.1016\/j.nephro.2009.02.006_bib98","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1016\/S0272-6386(04)01093-5","article-title":"Acute interstitial nephritis associated with atazanavir, a new protease inhibitor","volume":"44","author":"Brewster","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2009.02.006_bib99","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1056\/NEJMc061892","article-title":"Atazanavir urolithiasis","volume":"355","author":"Chang","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2009.02.006_bib100","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00002030-199301000-00024","article-title":"Dideoxyinosine-associated nephrotoxicity","volume":"7","author":"Crowther","year":"1993","journal-title":"AIDS"},{"key":"10.1016\/j.nephro.2009.02.006_bib101","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/01.aids.0000168985.05209.b8","article-title":"Fanconi syndrome associated with didanosine therapy","volume":"19","author":"Izzedine","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.nephro.2009.02.006_bib102","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00041552-200009000-00003","article-title":"Renal toxicity of protease inhibitors","volume":"9","author":"Olyaei","year":"2000","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.nephro.2009.02.006_bib103","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/ndt\/13.3.750","article-title":"Indinavir crystal deposits associated with tubulointerstitial nephropathy","volume":"13","author":"Martinez","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2009.02.006_bib104","first-page":"1801","article-title":"N\u00e9phrotoxicit\u00e9 du ritonavir","volume":"27","author":"Deray","year":"1998","journal-title":"Presse Med"},{"key":"10.1016\/j.nephro.2009.02.006_bib105","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1086\/508546","article-title":"Association between ABCC2 Gene haplotypes and tenofovir-induced proximal tubulopathy","volume":"194","author":"Izzedine","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.nephro.2009.02.006_bib106","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1097\/00002030-200404300-00019","article-title":"Renal safety of tenofovir in HIV treatment-experienced patients","volume":"18","author":"Izzedine","year":"2004","journal-title":"AIDS"}],"container-title":["N\u00e9phrologie &amp; Th\u00e9rapeutique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725509000455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725509000455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2009.02.006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:10:58Z","timestamp":1741191058000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769725509000455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":106,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S1769725509000455"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2009.02.006","relation":{},"ISSN":["1769-7255"],"issn-type":[{"value":"1769-7255","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}